Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development

What happened: Everest Medicines appointed Lakshmi Srinivasan, PhD, as Senior Vice President, Head of Translational Medicine, and Brandon Coder, PhD, as Vice President, Translational Sciences & Discovery. Both previously held oncology and cancer vaccine roles at Moderna. Key numbers: EVM16 Phase 1b investigator-initiated trial planned Q4 2026; U.S. Why it matters: The company says the hires strengthen its global mRNA R&D capabilities and support advancement of its mRNA platform and pipeline, including expanding its presence in the United States alongside its China R&D team.

Everest Medicines appointed Lakshmi Srinivasan, PhD, as Senior Vice President, Head of Translational Medicine, and Brandon Coder, PhD, as Vice President, Translational Sciences & Discovery. Both previously held oncology and cancer vaccine roles at Moderna.

The company says the hires strengthen its global mRNA R&D capabilities and support advancement of its mRNA platform and pipeline, including expanding its presence in the United States alongside its China R&D team.